Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Bio-XL Asia Pte Ltd is a Biotechnology Research brand in Singapore. The record marks it privately held. It holds one address on record, all in Singapore. It employs 1 person, on the record. It lists healthtech, commercialisation and medtech among its specialties. One Singapore registration (UEN) is a confirmed match. It is listed alongside two similar brands, mostly in Biotechnology Research.
UEN202131259N
| BIO-XL ASIA PTE. LTD. | UEN 202131259N |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Bio-XL Asia Pte Ltd (UEN 202131259N) selects innovative technologies and facilitates their development into new treatments or interventions.
We actively scout pre-IND therapeutic technology candidates or TRL 6-7 technologies and develops them into relevant markets in Asia, through licensing or other mutually beneficial commercial arrangement.
Target large patient populations in Asia with significant unmet needs. Current focus – oncology, rare disease, diabetes and ageing/longevity.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
One Singapore entity on ACRA: BIO-XL ASIA PTE. LTD. (UEN 202131259N), high confidence.
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 230 Victoria St, Bugis Junction Towers, Singapore.
None linked to this brand.
Four tags on the brand's own list, among them healthtech, commercialisation and medtech.
Two peer profiles on record: 2Strands Biosciences and RedFox Therapeutics.